BioLife Solutions Inc. (BLFS) Financial Statements (2025 and earlier)
Company Profile
Business Address |
3303 MONTE VILLA PARKWAY BOTHELL, WA 98021 |
State of Incorp. | DE |
Fiscal Year End | December 31 |
Industry (SIC) | 3845 - Electromedical and Electrotherapeutic Apparatus (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 51,695 | 62,702 | 69,860 | 90,403 | 6,448 | 30,657 | |||
Cash and cash equivalents | 35,407 | 19,442 | 69,860 | 90,403 | 6,448 | 30,657 | |||
Short-term investments | 16,288 | 43,260 | |||||||
Other undisclosed cash, cash equivalents, and short-term investments | |||||||||
Restricted cash and investments | 31 | 31 | 10 | 53 | |||||
Receivables | 18,657 | 33,936 | 23,217 | 8,006 | 5,345 | 3,045 | |||
Inventory, net of allowances, customer advances and progress billings | 43,456 | 34,904 | 28,345 | 11,602 | 10,972 | 3,509 | |||
Inventory | 43,456 | 34,904 | 28,345 | 11,602 | 10,972 | 3,509 | |||
Other undisclosed current assets | 6,765 | 6,879 | 4,427 | 4,648 | 1,348 | 353 | |||
Total current assets: | 120,604 | 138,452 | 125,859 | 114,712 | 24,113 | 37,564 | |||
Noncurrent Assets | |||||||||
Finance lease, right-of-use asset, after accumulated amortization | 94 | 272 | 440 | 17 | ✕ | ||||
Operating lease, right-of-use asset | 11,446 | 15,292 | 18,705 | 9,675 | 1,040 | ✕ | |||
Property, plant and equipment | 21,077 | 23,638 | 17,657 | 10,120 | 5,572 | 1,319 | |||
Debt securities, available-for-sale, accrued interest, after allowance for credit loss | 548 | 1,332 | ✕ | ✕ | |||||
Long-term investments and receivables | 548 | 1,332 | 6,548 | ||||||
Long-term investments | 548 | 1,332 | 6,548 | ||||||
Intangible assets, net (including goodwill) | 245,890 | 256,829 | 376,890 | 89,498 | 55,619 | ||||
Goodwill | 224,741 | 224,741 | 224,741 | 58,449 | 33,637 | ||||
Intangible assets, net (excluding goodwill) | 21,149 | 32,088 | 152,149 | 31,049 | 21,982 | ||||
Deposits noncurrent assets | 273 | 281 | 325 | 230 | 50 | 36 | |||
Other undisclosed noncurrent assets | 12,234 | 12,801 | 14,181 | 10,577 | 6,422 | ||||
Total noncurrent assets: | 292,110 | 311,777 | 428,198 | 120,117 | 68,703 | 7,903 | |||
TOTAL ASSETS: | 412,714 | 450,229 | 554,057 | 234,829 | 92,816 | 45,467 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Accounts payable and accrued liabilities, including: | 13,849 | 18,495 | 16,628 | 4,256 | 3,369 | 1,809 | |||
Taxes payable | ✕ | ✕ | ✕ | 27 | 112 | ||||
Employee-related liabilities | ✕ | ✕ | ✕ | 998 | |||||
Accounts payable | 6,940 | 15,367 | 14,945 | 3,672 | 3,119 | 720 | |||
Accrued liabilities | 6,909 | 3,128 | 1,656 | 472 | 3,369 | 91 | |||
Other undisclosed accounts payable and accrued liabilities | (3,119) | ||||||||
Deferred revenue | 661 | 548 | 814 | 931 | ✕ | ||||
Debt | 7,209 | 1,972 | 1,011 | 622 | |||||
Deferred compensation liability | 3,800 | 5,080 | 4,351 | 2,898 | |||||
Deferred rent credit | 130 | ||||||||
Derivative instruments and hedges, liabilities | 2,780 | ||||||||
Business combination, contingent consideration, liability | 2,138 | 5,127 | 2,637 | 377 | |||||
Other liabilities | 51 | 294 | 130 | ||||||
Other undisclosed current liabilities | 16,659 | 16,298 | 12,156 | 1,319 | 3,923 | ||||
Total current liabilities: | 42,178 | 44,582 | 40,381 | 15,573 | 7,669 | 1,939 | |||
Noncurrent Liabilities | |||||||||
Long-term debt and lease obligation | 19,480 | 23,919 | 23,110 | 8,769 | 550 | ||||
Long-term debt, excluding current maturities | 18,311 | 23,793 | 6,353 | ||||||
Finance lease, liability | 1,169 | 126 | 291 | 12 | ✕ | ||||
Liabilities, other than long-term debt | 13,393 | 17,540 | 10,429 | 5,241 | 41,143 | 380 | |||
Deferred rent credit | 349 | ||||||||
Deferred income tax liabilities | 188 | 250 | 5,487 | ✕ | |||||
Other liabilities | 10 | 42 | 726 | 4 | 31 | ||||
Operating lease, liability | 13,205 | 14,962 | 16,466 | 8,757 | 550 | ✕ | |||
Business combination, contingent consideration, liability | 2,318 | 4,900 | 4,515 | 1,537 | |||||
Derivative instruments and hedges, liabilities | 39,602 | ||||||||
Total noncurrent liabilities: | 32,873 | 41,459 | 33,539 | 14,010 | 41,693 | 380 | |||
Total liabilities: | 75,051 | 86,041 | 73,920 | 29,583 | 49,362 | 2,319 | |||
Equity | |||||||||
Equity, attributable to parent | 337,663 | 364,188 | 480,137 | 205,246 | 43,454 | 43,148 | |||
Common stock | 45 | 43 | 42 | 33 | 21 | 19 | |||
Additional paid in capital | 651,305 | 611,739 | 585,397 | 302,598 | 143,485 | 114,160 | |||
Accumulated other comprehensive loss | (345) | (679) | (282) | ||||||
Accumulated deficit | (313,342) | (246,915) | (105,020) | (97,385) | (100,052) | (71,031) | |||
Total equity: | 337,663 | 364,188 | 480,137 | 205,246 | 43,454 | 43,148 | |||
TOTAL LIABILITIES AND EQUITY: | 412,714 | 450,229 | 554,057 | 234,829 | 92,816 | 45,467 |
Income Statement (P&L) ($ in thousands)
9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
---|---|---|---|---|---|---|---|---|
Revenues | 143,271 | 161,759 | 119,156 | 48,087 | 27,371 | 19,742 | ||
Cost of revenue | (93,693) | (102,438) | (84,501) | (22,221) | (8,810) | (6,217) | ||
Cost of goods and services sold | (5,700) | (8,760) | (6,217) | |||||
Gross profit: | 49,578 | 59,321 | 34,655 | 25,866 | 18,561 | 13,525 | ||
Operating expenses | (120,403) | (204,862) | (68,595) | (31,441) | (18,781) | (9,863) | ||
Operating income (loss): | (70,825) | (145,541) | (33,940) | (5,575) | (220) | 3,662 | ||
Nonoperating income (expense) | 4,567 | 714 | 6,187 | 4,978 | (2,978) | (396) | ||
Investment income, nonoperating | 697 | 1,377 | 506 | |||||
Other nonoperating income (expense) | 1,264 | 704 | 289 | (13) | ||||
Interest and debt expense | 284 | (5) | (5) | |||||
Other undisclosed loss from continuing operations before equity method investments, income taxes | (284) | |||||||
Income (loss) from continuing operations before equity method investments, income taxes: | (66,258) | (144,827) | (27,753) | (597) | (3,203) | 3,261 | ||
Loss from equity method investments | (672) | |||||||
Other undisclosed income from continuing operations before income taxes | 5 | 677 | ||||||
Income (loss) from continuing operations before income taxes: | (66,258) | (144,827) | (27,753) | (597) | (3,198) | 3,266 | ||
Income tax expense (benefit) | (169) | 5,022 | 20,118 | 3,264 | 1,541 | |||
Income (loss) from continuing operations: | (66,427) | (139,805) | (7,635) | 2,667 | (1,657) | 3,266 | ||
Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (7,635) | 2,667 | (1,657) | 3,266 | |
Loss from discontinued operations | ||||||||
Net income (loss) attributable to parent: | (66,427) | (139,805) | (7,635) | 2,667 | (1,657) | 3,266 | ||
Preferred stock dividends and other adjustments | (339) | |||||||
Other undisclosed net loss available to common stockholders, basic | (217) | |||||||
Net income (loss) available to common stockholders, basic: | (66,427) | (139,805) | (7,635) | 2,450 | (1,657) | 2,927 | ||
Other undisclosed net loss available to common stockholders, diluted | (3,404) | |||||||
Net income (loss) available to common stockholders, diluted: | (66,427) | (139,805) | (7,635) | (954) | (1,657) | 2,927 |
Comprehensive Income ($ in thousands)
9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | 12/31/2018 | ||
---|---|---|---|---|---|---|---|---|
Net income (loss): | (66,427) | (139,805) | (7,635) | 2,667 | (1,657) | 3,266 | ||
Other comprehensive income | 334 | |||||||
Other undisclosed comprehensive income | ||||||||
Comprehensive income (loss): | (66,093) | (139,805) | (7,635) | 2,667 | (1,657) | 3,266 | ||
Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (397) | (282) | ||||||
Comprehensive income (loss), net of tax, attributable to parent: | (66,093) | (140,202) | (7,917) | 2,667 | (1,657) | 3,266 |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.